Financial News
Headline News about Incyte Corp
![](https://cdn.benzinga.com/files/images/story/2023/11/21/incy.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Incyte
November 21, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Incyte
October 30, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Expert Ratings for Incyte
September 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Incyte
August 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.chartmill.com/images/uploads/Undervalued_500_264px_webp_74997b3ff2.webp)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2023/09/18/incy.png?width=1200&height=800&fit=crop)
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Via Benzinga
Exposures
Product Safety
![](https://www.investors.com/wp-content/uploads/2018/09/stock-Incyte-01-shutter.jpg)
![](/next-assets/images/schema-image-default.png)
Incyte's Earnings Outlook
July 31, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2018/09/stock-Incyte-01-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/02/incy.png?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Incyte
May 01, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/01/incy.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_19.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/24/sndx.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/19/jim_cramer_shutterstock2.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/12/incy.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/11/sndx.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/737536/gettyimages-1027139762.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Via Talk Markets
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.